Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
2019 · Cell Death and Disease · 112 citations
https://doi.org/10.1038/s41419-019-1322-x
T
Tilman D. Rachner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
5.2K
Citations
30
h-index
61
i10-index
Tilman D. Rachner is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Bone health and treatments & Bone Metabolism and Diseases & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 30, co-authored 112 publications.
ORCID: 0000-0002-1592-4666Papers by this author
worksAnti-tumor effects of mevalonate pathway inhibition in ovarian cancer
2020 · BMC Cancer · 49 citations
https://doi.org/10.1186/s12885-020-07164-x
Dickkopf-1 is regulated by the mevalonate pathway in breast cancer
2014 · Breast Cancer Research · 36 citations
https://doi.org/10.1186/bcr3616
Fatal attraction: why breast cancer cells home to bone
2008 · Breast Cancer Research · 30 citations
https://doi.org/10.1186/bcr1848
Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells
2014 · Molecular Cancer · 23 citations
https://doi.org/10.1186/1476-4598-13-265
Small-molecule CBP/p300 histone acetyltransferase inhibition mobilizes leukocytes from the bone marrow via the endocrine stress response
2024 · Immunity · 16 citations
https://doi.org/10.1016/j.immuni.2024.01.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat